dr hyman glp 1 In 2022, we spent $5.8 billion on GLP-1 drugs like Ozempic—for adults without diabetes. Usage has more than tripled since 2018. Yes, these drugs can help with weight loss. But we have Dr. Mark Hyman on Why

Reviewing the mechanism of actionspecifically how it influences hunger, fullness, satisfaction, and food cravingscan help patients understand that weight loss results from a medication-induced calorie deficit, not from burning fat or boosting metabolism

CrossRef The emergent role of mitochondrial RNA modifications in metabolic alterations Hatim Boughanem, Yvonne Bttcher, Joo TomCarneiro, MaraCarmen Lpez de las Hazas, Alberto Dvalos, Akin Cayir, Manuel MaciasGonzlez WIREs RNA.2023;[Epub] CrossRef Ageassociated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis Jianrui Song, Diana Farris, Paola Ariza, Smriti Moorjani, Mita Varghese, Muriel Blin, Judy Chen, Daniel Tyrrell, Min Zhang, Kanakadurga Singer, Morgan Salmon, Daniel R

4

[1] mhra.gov.uk or via the Yellow Card app)